01
Oncology
US-produced chemotherapy, immunotherapy, and targeted therapies — including cutting-edge molecules still pending regulatory approval in other countries. We serve oncology clinics, oncology hospitals, specialized distributors, and patients undergoing treatment.
Category examples
- Immune checkpoint inhibitors (PD-1, PD-L1, CTLA-4)
- Targeted therapies (kinase inhibitors, anti-EGFR, anti-HER2)
- Cytotoxic chemotherapy
- CAR-T and cellular therapies